Bioinformatics analysis of rheumatoid arthritis tissues identifies genes and potential drugs that are expressed

Qingshan He1, Hanmeng Ding2

  • 1Nanyang Medical College, Henan, 473000, China.

Scientific Reports
|March 19, 2023
PubMed

Insights

Necroptosis-related genes, including FAS, MAPK8, and TNFSF10, show diagnostic potential for rheumatoid arthritis (RA). These key genes offer insights into RA mechanisms and the immune microenvironment, aiding in disease understanding.

Area of Science:

  • Immunology
  • Genetics
  • Cell Biology

Background:

  • Necroptosis, a regulated cell death, is implicated in diseases.
  • The specific role of necroptosis-related genes in rheumatoid arthritis (RA) remains unclear.

Purpose of the Study:

  • To identify and analyze necroptosis-related genes in rheumatoid arthritis (RA).
  • To explore the diagnostic potential and underlying mechanisms of these genes in RA.

Main Methods:

  • Downloaded RA data from GEO; identified necroptosis genes via KEGG and GSEA.
  • Utilized machine learning (LASSO, RF, SVM-RFE) to pinpoint key genes (FAS, MAPK8, TNFSF10).
  • Performed functional enrichment, drug-target prediction, ceRNA network, and CIBERSORT analyses.

Main Results:

  • Identified 113 RA-necroptosis associated genes linked to cytokine signaling and programmed necrosis.
  • FAS, MAPK8, and TNFSF10 were identified as key diagnostic genes for RA.
  • These genes are involved in immune signaling pathways and may modulate the RA immune microenvironment.

Conclusions:

  • FAS, MAPK8, and TNFSF10 show diagnostic potential for RA.
  • These genes provide mechanistic insights into RA pathogenesis and immune cell involvement.
  • Further clinical validation is needed to confirm their diagnostic utility in RA.

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.7K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.1K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.2K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
196